01 May 1998
Malignant melanoma of the anal canal: choosing between abdomino-perineal resection or local excision
Marek P. Nowacki, Piotr Liszka-Dalecki, Janusz Olędzki, Rafał Sopyło, Maciej Chwaliński, Krzysztof Bujko, Anna Nasierowska-GuttmejerMed Sci Monit 1998; 4(3): CR443-447 :: ID: 502424
Abstract
Records of 30 patients treated for malignant melanoma of the anal canal during the years 1948-96 were reviewed retrospectively. Most of them at the time of diagnosis were locally advanced - the median tumor diameter was 6.5 cm and the penetration of all tumors was deeper than 5 mm according to the Breslow classification. Surgery with intention of complete removal was performed on 25 of these patients and in 19 cases was considered to be microscopically complete: 7 abdominoperineal resections (APR) and 12 local excisions (LEX). Nine out of these 12 LEX were primarily done outside of our institution and can be considered only as excision biopsies. The median disease free survival time after APR was 4.25 month and after LEX was 9 month. Local recurrence was found in 4 out of 6 patients surviving after APR, and in 10 out of 12 after LEX. The median survival time after APR was 13 months, comparing with 21 months after LEX. Only one patient, a female, survived more than 5 years. She was treated by primary wide local excision, and the same procedure was done for her local recurrence. Two patients are still living 13 month after LEX + inguinal-iliac lymphadenectomy + radiation therapy without local recurrence or distant metastases. The authors support the hypothesis that survival of patients with malignant melanoma originating in the anal canal is not closely related to the aggressiveness of the primary surgery. The biology of the tumor and the clinical-pathological stage at presentation seem to be the most important prognostic factors. The authors believe that wide local excision should be recommended for all cases of 3 cm or less in diameter, and less than 3 mm of penetration according to the Breslow staging system. APR may be the procedure of choice for bigger and more penetrating lesions. Radiation therapy should be more widely employed, particularly in cases after LEX and in cases when primary surgery is contraindicated.
Keywords: anorectal melanoma, abdomino-perineal resection, local excision
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952